BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24255131)

  • 1. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma.
    Zhao Y; Li Y; Ma H; Dong W; Zhou H; Song X; Zhang J; Jia L
    Mol Cell Proteomics; 2014 Feb; 13(2):520-36. PubMed ID: 24255131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
    Ma H; Zhou H; Song X; Shi S; Zhang J; Jia L
    Oncogene; 2015 Feb; 34(6):726-40. PubMed ID: 24531716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
    Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
    J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ST6Gal-I expression in human hepatocellular carcinoma cells inhibits their exosome-mediated proliferation- and migration-promoting effects.
    Wang L; Chen X; Wang L; Wang S; Li W; Liu Y; Zhang J
    IUBMB Life; 2021 Nov; 73(11):1378-1391. PubMed ID: 34559939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
    Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
    Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHST11/13 Regulate the Metastasis and Chemosensitivity of Human Hepatocellular Carcinoma Cells Via Mitogen-Activated Protein Kinase Pathway.
    Zhou H; Li Y; Song X; Zhao Y; Cheng L; Zhao L; Jia L
    Dig Dis Sci; 2016 Jul; 61(7):1972-85. PubMed ID: 26993826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
    Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
    Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis.
    Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY
    BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
    Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
    J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor α-mediated β-galactoside α2,6-sialyltransferase I expression in human hepatocarcinoma cells.
    Chen X; Wang L; Yu X; Wang S; Zhang J
    Int J Biochem Cell Biol; 2021 Aug; 137():106027. PubMed ID: 34157397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.
    Fan Q; He M; Deng X; Wu WK; Zhao L; Tang J; Wen G; Sun X; Liu Y
    Cell Biochem Funct; 2013 Jun; 31(4):319-24. PubMed ID: 23001723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes.
    Zhang Z; Sun J; Hao L; Liu C; Ma H; Jia L
    PLoS One; 2013; 8(6):e65218. PubMed ID: 23840320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.
    Souady J; Hülsewig M; Distler U; Haier J; Denz A; Pilarsky C; Senninger N; Dreisewerd K; Peter-Katalinic J; Müthing J
    Glycobiology; 2011 May; 21(5):584-94. PubMed ID: 21147760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST6GalNAcII mediates tumor invasion through PI3K/Akt/NF-κB signaling pathway in follicular thyroid carcinoma.
    Miao X; Zhao Y
    Oncol Rep; 2016 Apr; 35(4):2131-40. PubMed ID: 26820593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4.
    Ma X; Dong W; Su Z; Zhao L; Miao Y; Li N; Zhou H; Jia L
    Cell Death Dis; 2016 Dec; 7(12):e2561. PubMed ID: 28032858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
    Chen K; Zhang S; Ji Y; Li J; An P; Ren H; Liang R; Yang J; Li Z
    PLoS One; 2013; 8(9):e72927. PubMed ID: 24039823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.